$3.23
-0.03-0.92%
Pre-Market: 5:14 PM EDT
Comments
Loading...
aTyr Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ATYR | Benzinga
aTyr Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.250
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$235.00K
Analyze the earnings history of aTyr Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATYR | aTyr Pharma | -$0.23 | -$0.25 | — | — | $235.00K | — | — | — | 05/01/2025 | Get Alert |
| ATYR | aTyr Pharma | -$0.25 | -$0.23 | -$0.18 | 21.74% | $0.00 | — | $0.00 | — | 03/13/2025 | Get Alert |
| ATYR | aTyr Pharma | -$0.20 | -$0.22 | -$0.23 | -4.55% | $353.00K | $20.00K | $0.00 | -100.00% | 11/07/2024 | Get Alert |
| ATYR | aTyr Pharma | -$0.22 | -$0.25 | -$0.23 | 8.00% | $0.00 | — | $0.00 | — | 08/13/2024 | Get Alert |
| ATYR | aTyr Pharma | -$0.29 | -$0.24 | -$0.23 | 4.17% | $0.00 | $20.00K | $235.00K | 1075.00% | 05/02/2024 | Get Alert |
| ATYR | aTyr Pharma | -$0.26 | -$0.24 | -$0.25 | -4.17% | $10.39M | $50.00K | $0.00 | -100.00% | 03/14/2024 | Get Alert |
| ATYR | aTyr Pharma | -$0.46 | -$0.23 | -$0.20 | 13.04% | $0.00 | $1.50M | $353.00K | -76.47% | 11/09/2023 | Get Alert |
| ATYR | aTyr Pharma | -$0.44 | -$0.28 | -$0.22 | 21.43% | $0.00 | $520.00K | $0.00 | -100.00% | 08/09/2023 | Get Alert |
| ATYR | aTyr Pharma | -$0.44 | -$0.40 | -$0.29 | 27.50% | $0.00 | $300.00K | $0.00 | -100.00% | 05/09/2023 | Get Alert |
| ATYR | aTyr Pharma | -$0.31 | -$0.48 | -$0.26 | 45.83% | $0.00 | $210.00K | $10.39M | 4845.71% | 03/09/2023 | Get Alert |
| ATYR | aTyr Pharma | -$0.42 | -$0.46 | -$0.46 | 0.00% | $0.00 | $330.00K | $0.00 | -100.00% | 11/10/2022 | Get Alert |
| ATYR | aTyr Pharma | -$0.64 | -$0.38 | -$0.44 | -15.79% | $0.00 | $2.00M | $0.00 | -100.00% | 08/15/2022 | Get Alert |
| ATYR | aTyr Pharma | -$0.51 | -$0.33 | -$0.44 | -33.33% | $0.00 | $170.00K | $0.00 | -100.00% | 05/09/2022 | Get Alert |
| ATYR | aTyr Pharma | -$0.47 | -$0.28 | -$0.31 | -10.71% | $2.05M | $3.02M | $0.00 | -100.00% | 03/14/2022 | Get Alert |
| ATYR | aTyr Pharma | -$0.68 | -$0.60 | -$0.42 | 30.00% | $148.00K | $230.00K | $0.00 | -100.00% | 11/10/2021 | Get Alert |
| ATYR | aTyr Pharma | -$0.69 | -$0.51 | -$0.64 | -25.49% | $189.00K | $620.00K | $0.00 | -100.00% | 08/10/2021 | Get Alert |
| ATYR | aTyr Pharma | $0.25 | -$0.34 | -$0.51 | -50.00% | $8.06M | $3.58M | $0.00 | -100.00% | 05/13/2021 | Get Alert |
| ATYR | aTyr Pharma | -$1.54 | -$0.82 | -$0.47 | 42.68% | $144.00K | $130.00K | $2.05M | 1479.23% | 03/23/2021 | Get Alert |
| ATYR | aTyr Pharma | -$1.47 | -$0.74 | -$0.68 | 8.11% | $184.00K | $100.00K | $148.00K | 48.00% | 11/12/2020 | Get Alert |
| ATYR | aTyr Pharma | -$1.80 | -$0.73 | -$0.69 | 5.48% | $94.00K | — | $189.00K | — | 08/13/2020 | Get Alert |
| ATYR | aTyr Pharma | -$2.52 | -$0.18 | $0.25 | 238.89% | $0.00 | $4.40M | $8.06M | 83.30% | 05/12/2020 | Get Alert |
aTyr Pharma (ATYR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.18 | $-0.23 | 21.7 % |
| Q3 | 2024-11-07 | $-0.23 | $-0.22 | -4.55 % |
| Q2 | 2024-08-13 | $-0.23 | $-0.25 | 8.00 % |
| Q1 | 2024-05-02 | $-0.23 | $-0.24 | 4.17 % |
aTyr Pharma (ATYR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $0 | $20.00K | -100.0 % |
| Q1 | 2024-05-02 | $235.00K | $20.00K | 1075.0 % |
| Q4 | 2024-03-14 | $0 | $50.00K | -100.0 % |
| Q3 | 2023-11-09 | $353.00K | $1.50M | -76.5 % |
FAQ
When is aTyr Pharma (NASDAQ:ATYR) reporting earnings?
aTyr Pharma (ATYR) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for aTyr Pharma (NASDAQ:ATYR)?
The Actual EPS was $-0.18, which beat the estimate of $-0.23.
What were aTyr Pharma’s (NASDAQ:ATYR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.